Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Retinal
Sort By
Newest First
1 / 1
1 / 1
Ophthalmology
The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success
Tracey Roberts, MSHS; Jennifer Christiansen, Ph.D.; Debra Schaumberg, Sc.D., O.D., M.P.H.
PPD, part of Thermo Fisher Scientific
PAO-08-24-CL-05
Sep 16, 2024
Retinal Disease
Pioneering Breakthroughs in Retinal Disease Treatment
David Alvaro, Ph.D.; David Zacks, M.D., Ph.D.; David Esposito
Pharma's Almanac
PAO-12-23-CL-01
Dec 14, 2023
Ophthalmic
Transformative Early and Patient-Centric Treatments for Retinal Diseases
David Alvaro, Ph.D.; Kerrie Brady
Pharma's Almanac
PAO-05-022-CL-06
May 17, 2022
Ophthalmic Formulation
Targeting Retinal Diseases with an Ophthalmic Formulation of Bevacizumab
Larry Kenyon
Outlook Therapeutics
PAP-Q4-20-CL-018
Dec 09, 2020
Ophthalmology
Innovative Therapies to Treat Rare and Underserved Eye Diseases
Shankar Musunuri, Ph.D.
Ocugen
PAP-Q4-19-CL-025
Dec 06, 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics
PR-M01-19-NI-096
Feb 01, 2019
Retinal Cell Replacement Therapy
ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBC
ProtoKinetix
PR-M09-18-NI-001
Sep 04, 2018
